Natures Sunshine Products INC

Natures Sunshine announced a 2% net sales increase to $117.0 million and a 194 basis point improvement in gross profit margin for Q2 2026, alongside the appointment of Ruth Perkins as EVP and CFO.

Natures Sunshine Products, Inc. announced the resignation of its CFO, L. Shane Jones, effective June 5, 2026, and the appointment of Jonathan D. Lanoy as interim Principal Financial Officer.

Nature's Sunshine reported a 9% increase in Q1 2026 net sales to $122.9 million and received shareholder approval for its 2026 Stock Incentive Plan.

Natures Sunshine Products reports strong third-quarter 2025 financial results with net sales up 12% to $128.3 million and a raised full-year outlook.

Natures Sunshine Products, Inc. announced the appointment of Kenneth Romanzi as its new Chief Executive Officer, succeeding Terrence O. Moorehead, effective October 29, 2025.

Nature's Sunshine Products, Inc. announced robust second-quarter 2025 financial results, featuring increased net sales and adjusted EBITDA, leading to an upward revision of its full-year guidance.

Natures Sunshine Products reported a 1.9% increase in net sales for Q2 2026, reaching $117.0 million, driven by growth in Asia, Europe, and North America, though net income declined.

Nature's Sunshine Products reported an 8.5% increase in Q1 2026 net sales to $122.9 million, driven by growth across all geographic segments.

Natures Sunshine Products, Inc. announced significant increases in net sales and net income for the third quarter and first nine months of 2025, alongside the appointment of Kenneth G. Romanzi as its new Chief Executive Officer.

Nature's Sunshine Products, Inc. announced a significant increase in net income and earnings per share for the second quarter and first half of 2025, driven by sales growth, improved gross margins, and favorable foreign exchange dynamics, alongside a strategic move to acquire full ownership of its China joint ventures.

Natures Sunshine Products saw a 2.0% increase in consolidated net sales for Q1 2025, driven by growth in Asia and Europe, despite headwinds from foreign exchange rates.

Natures Sunshine Products saw a slight increase in net sales in Q3 2024, but faced challenges from inflation and currency fluctuations.

Natures Sunshine Products experienced a slight increase in consolidated net sales for 2024, but faces ongoing challenges including regulatory scrutiny and global economic pressures.

Natures Sunshine Products Inc. reports a 5.5% increase in consolidated net sales for 2023, alongside identifying a material weakness in internal controls related to unauthorized wire transfers.

Prescott Group Capital Management, L.L.C. and 4 others reported changes in beneficial ownership of Natures Sunshine Products Inc common stock on August 17, 2026.

Prescott Group Capital Management, L.L.C. and 4 others reported changes in beneficial ownership of Natures Sunshine Products Inc common stock on August 6, 2026.

Kevin R. Herbert, EVP & President, North America for Nature's Sunshine Products Inc., reported a transaction involving the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

EVP and President of North America Kevin R. Herbert sold 2,000 shares of Nature's Sunshine Products, Inc. (NATR) on June 12, 2026.

Bryant J. Yates, EVP & President of Europe at Nature's Sunshine Products, sold 11,968 shares of common stock.

Daniel C. Norman, EVP & President of Asia at Nature's Sunshine Products, sold 9,713 common shares at $20.64 per share.

Nature's Sunshine Products, Inc. announces its 2026 Annual Meeting of Shareholders to address director elections, executive compensation, auditor ratification, and a new stock incentive plan.

Nature's Sunshine Products will hold its 2025 Annual Meeting of Shareholders on April 30, 2025, to elect directors, approve executive compensation, and ratify the appointment of its independent accounting firm.

A preliminary proxy statement has been filed, indicating upcoming corporate actions requiring shareholder votes.

Nature's Sunshine Products, Inc. has released its definitive proxy statement, outlining proposals for the upcoming 2024 Annual Meeting of Shareholders, including the election of directors, executive compensation, and ratification of the company's accounting firm.

Fosun Pharma USA Inc. has completed the sale of over 2.8 million shares of Nature's Sunshine Products Inc. common stock, reducing its beneficial ownership to below 5%.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has transferred 2,854,607 shares of Nature's Sunshine Products, Inc. common stock to its wholly-owned U.S. subsidiary, Fosun Pharma USA Inc., as disclosed in an amended Schedule 13D filing.

Prescott Group Capital Management and affiliated entities report maintaining a 10.9% beneficial ownership in Nature's Sunshine Products, Inc. as of August 6, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.04% of Nature's Sunshine Products, Inc. common stock as of September 30, 2025.

Dimensional Fund Advisors LP has reported a 5.2% beneficial ownership stake in Nature's Sunshine Products Inc., held for investment advisory purposes.